- Crown Trading
- Posts
- Crown's Top 3 Stock Picks For The Week
Crown's Top 3 Stock Picks For The Week
Here are our top 3 stock picks for the week...
GOOD MORNING
Here’s everything you need to know today: There are currently 14,157 publicly traded companies in the United States and over 1000+ articles released about S&P500 companies alone every single day. Today we will be showing you our top 3 stock picks we have hand picked for this week:
1 year performance
TOST - 52%
EAT - 237%
HIMS - 112%
This Week (Here’s our top 3 stock picks)
Toast Inc (TOST)

1 Year Performance: +52%
Category: Growth
Market Cap: $19.7B
Company Info:
Toast, Inc. (NYSE: TOST) is a cloud-based technology company that provides an all-in-one platform for the restaurant industry, offering point-of-sale systems, digital ordering, delivery, marketing, and team management solutions. Serving over 120,000 restaurant locations across the United States and internationally, Toast's integrated software and hardware solutions help restaurants streamline operations, enhance guest experiences, and drive revenue growth.
Why it’s a buy:
Toast, Inc. (NYSE: TOST) presents a compelling investment opportunity due to its robust financial performance, expanding customer base, and strategic growth initiatives in the restaurant technology sector. In 2024, Toast achieved its first full year of GAAP profitability, reporting net income of $19 million and adjusted EBITDA of $373 million, a significant increase from the previous year's figures.
The company added a record 28,000 net new locations, ending the year with approximately 134,000 locations, and saw its annualized recurring run-rate (ARR) grow by 34% to over $1.6 billion . Additionally, Toast's gross payment volume (GPV) increased by 26% year-over-year to $159.1 billion, indicating strong adoption of its payment processing solutions.
The company's expansion into new verticals, such as hotels and retail, and partnerships with notable restaurant chains like Perkins and Mendocino Farms, further enhance its growth prospects . With a strong balance sheet, improving cash flow, and a growing market presence, Toast is well-positioned for sustained growth and long-term value creation.
Revenue:

Brinker International Inc (EAT)

1 Year Performance: +237%
Category: Growth
Market Cap: $6.8B
Company Info:
Brinker International, Inc. is a multinational casual dining restaurant company headquartered in Dallas, Texas, operating and franchising over 1,600 restaurants across 31 countries and two territories. Its portfolio includes well-known brands such as Chili's® Grill & Bar, Maggiano's Little Italy®, and the virtual brand It's Just Wings®, offering a variety of American and Italian cuisine to a global customer base.
Why it’s a buy:
Brinker International, Inc. (NYSE: EAT) presents a compelling investment opportunity due to its robust financial performance, operational efficiency, and strong brand momentum.
In Q2 fiscal 2025, the company reported total revenues of $1.36 billion, a 27% year-over-year increase, and net income of $118.5 million, up from $42.1 million the previous year. Comparable restaurant sales rose by 27.4%, with Chili’s leading at 31.4%, driven by a 19.9% increase in traffic resulting from effective advertising and operational improvements.
The restaurant operating margin improved to 19.1%, reflecting enhanced operational efficiency. Brinker has updated its full-year fiscal 2025 guidance, projecting revenues between $5.15 billion and $5.25 billion and adjusted EPS of $7.50 to $8.00, indicating confidence in sustained growth.
These factors, combined with a strong brand portfolio and strategic initiatives, position Brinker International for continued success in the casual dining sector.
Revenue:

Hims & Hers Health Inc (HIMS)

1 Year Performance: +112%
Category: Growth
Market Cap: $6B
Company Info:
Hims & Hers Health, Inc. is a telehealth company that offers digital healthcare services and personalized wellness products, including prescription medications, over-the-counter treatments, and mental health support. Through its online platform, users can consult with licensed healthcare providers and receive tailored treatment plans for conditions such as hair loss, sexual health, mental health, skincare, and weight management.
Why it’s a buy:
Hims & Hers Health, Inc. (NYSE: HIMS) is a compelling investment opportunity due to its strong financial performance, expanding subscriber base, and strategic initiatives in personalized healthcare.
In 2024, the company achieved revenue of $1.48 billion, marking a 69% increase year-over-year, and reported net income of $126 million, transitioning from a net loss in the previous year.
The subscriber base grew to 2.2 million, up 45% from the prior year, reflecting increased demand for its digital health services. Despite regulatory changes affecting its compounded GLP-1 offerings, Hims & Hers projects 2025 revenue between $2.3 billion and $2.4 billion, indicating confidence in its diversified product portfolio and growth strategies.
The company's focus on expanding personalized treatments, including at-home lab testing and new weight loss solutions, positions it well for sustained growth in the evolving telehealth market.
Revenue:


Get more picks like Hims…
If you are interested in receiving more of our top stock picks like Hims sign up to our Elite Membership where you get access to:
3 curated emails a week (monday, wednesday, friday) with 2 hand-picked Elite stocks in each email
1 report a week (sunday) on the general market and state of where the stock market is it currently
Direct email contact with myself to ask any questions regarding stock knowledge
Exclusive offers from any of our partners (trade software, brokers, news sources, etc.)
2 week money back guarantee (100% refund)
Join today for only $19.99/month or $199.99/year.
Otherwise, stay tuned for our next free release at 8:15 am EST (Monday and Friday).

OUR RECENT ELITE TRADES (updated Mar 12/25)
Date Posted | Ticker | Price | Current Price | Gain/Loss |
---|---|---|---|---|
Jan 10/25 | SE | $105 | $129 | 22.8% |
Jan 13/25 | DOCS | $49 | $64 | 30.6% |
Jan 15/25 | SPOT | $476 | $535 | 12.4% |
Jan 10/25 | BB | $3.9 | $4.37 | 12.1% |
Jan 13/25 | DAVE | $86 | $81 | 6.1% |
If you invested $10,000 in each of these stocks you’d be sitting on:
$58,340
In less than 2 months...
Join Crown Elite today for only $19.99/month or $199.99/year
and get our Elite Picks Emailed to you every Monday, Wednesday and Friday.

Thank you for your time!
I’m sure you get hundreds of emails a day so I thank you for taking the time to read ours. Please follow us on our social media channels below where we post other new and different content related to investing, personal finance, and trading.
Stay tuned for our next free release at 8:15 am EST (Monday and Friday).